Ads
related to: merck
Search results
Merck to Acquire EyeBio
Morningstar· 17 hours agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
Reuters via Yahoo Finance· 17 hours ago(Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion,...
Merck KGaA (MKGAF) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance· 12 hours agoMerck KGaA (MKGAF) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2...
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 13 hours agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 10 hours agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 6 hours agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown...
Merck Nears $1.3 Billion Cash Deal for Eye-Drug Company EyeBio, WSJ Reports
US News & World Report· 1 day agoMerck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to comment. Eyebiotech is a clinical stage opthalmology company, with operations ...
Surmodics Stock Rockets, But Merck Stock Little Moved, On Takeover Deals
Investor's Business Daily· 8 hours agoDow Jones stalwart Merck and Surmodics announced big takeover deals Wednesday, but Merck stock...
Merck To Pay as Much as $3 Billion for Eye Treatment Startup
Bloomberg· 17 hours agoHave a confidential tip for our reporters? Merck & Co. restocked its cabinet of eye treatments with...
Merck acquires EyeBio in up to $3B deal By Proactive Investors
Investing.com· 8 hours agoMerck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held...